Definium Therapeutics (DFTX) operating margin

There is no operating margin history on record here for Definium Therapeutics (DFTX). Figures as of 17 Nov 2026, 18:21 UTC, from the company's filings with the SEC and Yahoo Finance.

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Not enough data

A history of operating margin needs at least 3 fiscal years; none is on record here for Definium Therapeutics. Nothing is estimated to fill the gap.

Method

How it is calculated

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

How to read it

It shows how much of each unit of sales survives the cost of running the business — rising margins point to pricing power or scale, falling ones to pressure.

Operating margin at health care companies of similar size

Operating margin of Definium Therapeutics and comparable companies
CompanyOperating marginFiscal year
Heartflow HTFL-36.4%2025
CRISPR Therapeutics CRSP-1333.0%2024
Travere Therapeutics TVTX-12.8%2025
Option Care Health OPCH6.0%2025
Legend Biotech LEGN-13.3%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on DFTX

Definium Therapeutics, figure by figure

Definium Therapeutics (DFTX) overview: price, valuation and scorecardAll health care companies by market value

Definium Therapeutics operating margin: questions and answers

How is Definium Therapeutics's operating margin calculated?

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Definium Therapeutics (DFTX) operating margin”, data as of 17 November 2026. https://funkfolio.com/stock/DFTX/operating-margin

Underlying data: the company's filings with the SEC and Yahoo Finance.